dihydroxyphenylalanine has been researched along with Dejerine-Thomas Syndrome in 3 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Striatal 18F-Dopa uptake and brain glucose metabolism were studied by PET with 6-L-[18F]flurodopa and [18F]fluorodeoxyglucose in 11 patients with syndrome of progressive ataxia." | 5.07 | Striatal 18F-dopa uptake and brain glucose metabolism by PET in patients with syndrome of progressive ataxia. ( Akashi, Y; Fukumura, T; Goto, I; Hosokawa, S; Ichiya, Y; Kato, M; Kuwabara, Y; Masuda, K; Otsuka, M; Yoshida, T, 1994) |
| "Ten patients with sporadic olivopontocerebellar atrophy and autonomic failure were studied with positron emission tomography." | 1.29 | Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. ( Brooks, DJ; Burn, DJ; Marsden, CD; Mathias, CJ; Quinn, NP; Rinne, JO, 1995) |
| "When all three categories of Parkinson's disease, MSA, and SRO were considered together, clinical and 18F-dopa PET findings correlated in 64% of patients assigned a diagnosis of Parkinson's disease and 70% of those given a diagnosis of SRO; MSA was less readily discriminated, patients with MSA being assigned to MSA, Parkinson's disease, and SRO groups with equal frequency." | 1.29 | Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. ( Brooks, DJ; Burn, DJ; Sawle, GV, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rinne, JO | 1 |
| Burn, DJ | 2 |
| Mathias, CJ | 1 |
| Quinn, NP | 1 |
| Marsden, CD | 1 |
| Brooks, DJ | 2 |
| Otsuka, M | 1 |
| Ichiya, Y | 1 |
| Kuwabara, Y | 1 |
| Hosokawa, S | 1 |
| Akashi, Y | 1 |
| Yoshida, T | 1 |
| Fukumura, T | 1 |
| Masuda, K | 1 |
| Goto, I | 1 |
| Kato, M | 1 |
| Sawle, GV | 1 |
1 trial available for dihydroxyphenylalanine and Dejerine-Thomas Syndrome
| Article | Year |
|---|---|
Striatal 18F-dopa uptake and brain glucose metabolism by PET in patients with syndrome of progressive ataxia.
Topics: Adult; Aged; Ataxia; Atrophy; Brain Chemistry; Brain Stem; Cerebellum; Deoxyglucose; Dihydroxyphenyl | 1994 |
2 other studies available for dihydroxyphenylalanine and Dejerine-Thomas Syndrome
| Article | Year |
|---|---|
Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy.
Topics: Autonomic Nervous System Diseases; Carbon Radioisotopes; Corpus Striatum; Dihydroxyphenylalanine; Di | 1995 |
Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data.
Topics: Adult; Aged; Analysis of Variance; Caudate Nucleus; Corpus Striatum; Diagnosis, Differential; Dihydr | 1994 |